P2.14-46 Treatment Observations and Clinical Experience with Lorlatinib in Pretreated ALK and ROS1 Rearranged NSCLC Patients
| Autor: | Hochmair, M.J., Weinlinger, C., Fabikan, H., Illini, O., Krenbek, D., Setinek, U., Watzka, S., Koger, R., Meilinger, M., Absenger, G., Wanke, M., Semmelweis, C., Rauter, M., Valipour, A. |
|---|---|
| Zdroj: | In Journal of Thoracic Oncology October 2019 14(10) Supplement:S847-S847 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|